Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 2 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Integrated Phenotyping of the Gut-plAtelet-Liver AXIS in the Progression of Chronic Liver Disease (iGAL-AXIS)Not yet recruitingNCT06623084
- Hyperbaric Oxygen Therapy for Metabolic Dysfunction-associated Steatotic Liver DiseasesRecruitingNCT06619808Not applicable
- Intermittent Fasting, Mediterranean Diet and NAFLDNot yet recruitingNCT06615817Not applicable
- Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University HospitalNot yet recruitingNCT06601361
- Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)RecruitingNCT06599918Phase 2
- Lifestyle Changes in Fatty Liver; Additive Effect of Honey IntakeRecruitingNCT06596109Not applicable
- Lifestyle Changes in PCOS with OSA and NAFLDRecruitingNCT06591169Not applicable
- Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBVNot yet recruitingNCT06589167
- Digoxin In NASH (CODIN)RecruitingNCT06588699Phase 2
- Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile AnalysisRecruitingNCT06585982Not applicable
- Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)RecruitingNCT06571474
- Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)RecruitingNCT06569524Phase 2
- The Liver BIoBank Lombardia of Fatty LiverRecruitingNCT06566105Not applicable
- Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLDRecruitingNCT06564584Phase 2
- RE and Probiotics in MAFLD/NAFLDNot yet recruitingNCT06563921Not applicable
- Hepatic Mitochondrial Metabolism in Fatty Liver Disease in HumansEnrolling by invitationNCT06559878Not applicable
- Human Models of Selective Insulin Resistance: Pancreatic ClampNot yet recruitingNCT06558422Phase 1
- Ketogenic Diet in MASLD-related cACLDNot yet recruitingNCT06537466Not applicable
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHRecruitingNCT06528314Phase 3
- Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through ExerciseNot yet recruitingNCT06520800Not applicable
- Reducing Non-Alcoholic SteatohepatitisEnrolling by invitationNCT06519448Not applicable
- Liver-gut Axis Study Through Identification of Liver Disease-specific MicrobiomeRecruitingNCT06519162
- Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver DiseaseRecruitingNCT06512701
- Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty LiverRecruitingNCT06508190Not applicable
- Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian PatientsRecruitingNCT06503068
- Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingNCT06501326Phase 4
- Milk Thistle Clinical Trial in Pediatric NAFLDRecruitingNCT06477146Phase 2
- A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With CirrhosisRecruitingNCT06461208Phase 3
- Aronia and Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06450769Not applicable
- Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLDRecruitingNCT06449833Phase 4
- Prevalence of NAFLD in T1DM PatientsRecruitingNCT06445361Not applicable
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHRecruitingNCT06419374Phase 3
- Safety of DNP007 in Healthy SubjectsRecruitingNCT06400771Phase 1
- Fibrosis Lessens After Metabolic SurgeryRecruitingNCT06374875Phase 4
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）RecruitingNCT06368882Phase 4
- Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver DiseaseRecruitingNCT06355310Phase 2
- Human Models of Selective Insulin Resistance: Alpelisib, Part IRecruitingNCT06354088Phase 1
- Effect of Consumption of Millet Diet in Patients With NAFLDNot yet recruitingNCT06341790Not applicable
- Harnessing Macrophage Lysosomal Lipid Metabolism in ObesityRecruitingNCT06335771Not applicable
- Target of Suv420h1/2 in HepatocytesRecruitingNCT06332677Not applicable
- Clinical Characteristics of Metabolic Associated Fatty Liver DiseaseRecruitingNCT06325254
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)RecruitingNCT06318169Phase 3
- Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With FibrosisRecruitingNCT06308757Not applicable
- Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic SteatohepatitisRecruitingNCT06302049Phase 1/2
- Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06266559Not applicable
- Different Exercise Modalities in the Treatment of NAFLD and Their Impact on MyokinesRecruitingNCT06257732Not applicable
- Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary SyndromeNot yet recruitingNCT06256289Phase 4
- Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)RecruitingNCT06225713Not applicable
- Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06218342Phase 4
- To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy SubjectsRecruitingNCT06216041Phase 1
- Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort StudyRecruitingNCT06211868
- Liver Steatosis in Pediatric CD PatientsRecruitingNCT06206616
- A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing AtarRecruitingNCT06193629Not applicable
- Effects of Two Different Exercise Programs and Diet in Obese Subjects With NAFLDRecruitingNCT06186869Not applicable
- Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric SurgeryNot yet recruitingNCT06180928
- The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind TrialNot yet recruitingNCT06167902Not applicable
- Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver DiseaseNot yet recruitingNCT06166797
- Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic SteatohepatitisNot yet recruitingNCT06160271Phase 2
- Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for EfficacyEnrolling by invitationNCT06152991Phase 3
- Characterization of the Intrahepatic Inflammatory Microenvironment in Patients With Non-alcoholic SteatohepatitisRecruitingNCT06152250Not applicable
- The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 DiabetesRecruitingNCT06144593Not applicable
- Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled TrialRecruitingNCT06138821Not applicable
- Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)RecruitingNCT06133101Phase 2
- Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver DiseaseNot yet recruitingNCT06130202
- Vigorous- Versus Moderate-intensity Exercise to Reduce Liver Fat in Adults With Obesity and NAFLDRecruitingNCT06124456Not applicable
- Androgens and NAFLD Longitudinal Cohort StudyRecruitingNCT06124261
- Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) ProgramRecruitingNCT06115876
- Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER StudyRecruitingNCT06101758Not applicable
- UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)RecruitingNCT06080386
- Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort StudyRecruitingNCT06078722
- Liver Fat Content and Bariatric SurgeryRecruitingNCT06064240
- Effect of Timed-Restricted Eating on Metabolic HealthRecruitingNCT06061042Not applicable
- Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 DiabetesRecruitingNCT06035874Not applicable
- Calisthenics Versus High Intensity Interval Training in NAFLRecruitingNCT06032650Not applicable
- Comorbidities Resolution After MGB Surgery and Change in Body CompositionRecruitingNCT06015620
- Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in AssiutNot yet recruitingNCT06009250
- Psoriasis and Non Alcoholic Steatohepatitis: Is There a Shared Inflammatory Network ?Not yet recruitingNCT05994677
- The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?Not yet recruitingNCT05987748Not applicable
- Bicalutamide Therapy in Young Women With NAFLD and PCOSRecruitingNCT05979389Phase 1
- Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional StudyRecruitingNCT05974904
- Diet, Immunometabolism and Non-alcoholic Fatty Liver DiseaseRecruitingNCT05968378Not applicable
- Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT05966025Phase 2
- Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable
- Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLDNot yet recruitingNCT05942963Phase 4
- the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.RecruitingNCT05942547Phase 3
- The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial FunctionRecruitingNCT05941910Phase 2
- Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver DiseaseRecruitingNCT05913986Not applicable
- Cardio-Metabolic Risk Evaluation in Overweight and Obese ChildrenNot yet recruitingNCT05908877
- Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver DiseaseNot yet recruitingNCT05908006
- Omics Techniques in Fatty Liver DiseaseNot yet recruitingNCT05907408
- Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients.Not yet recruitingNCT05894993
- Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight IndividualsRecruitingNCT05890365
- Preoperative Ketogenic Diet for Reduction of Hepatic SteatosisRecruitingNCT05884723Not applicable
- NAC- NAFLD And CushingRecruitingNCT05881005Not applicable
- A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With ComorbiditiesRecruitingNCT05872269Phase 4
- Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)RecruitingNCT05870969
- Non-alcoholic Fatty Liver Disease in Low Birth Weight IndividualsRecruitingNCT05842850Not applicable
- Study of ADI-PEG 20 Versus Placebo in Subjects With NASHRecruitingNCT05842512Phase 2
- Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesRecruitingNCT05832229Phase 2
- Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.Not yet recruitingNCT05822622